What led to the significant revenue drop in fiscal year 2002?

The substantial decrease in revenue from $1.52 billion in FY2001 to $943.1 million in FY2002 was primarily driven by a severe contraction in the semiconductor manufacturing equipment market. This was a result of a global decline in demand for integrated circuits, leading to excess capacity among semiconductor manufacturers who subsequently reduced their capital expenditures.

How did Lam Research manage costs and operational efficiency during this downturn?

Lam Research implemented significant cost management programs, including substantial restructuring charges totaling $44.8 million in FY2002. They also entered into agreements to outsource elements of their manufacturing, warehousing, logistics, and IT functions to gain flexibility in scaling operations and responding to the cyclical nature of the business. Reductions in R&D and SG&A expenses were also pursued where possible.

What is the outlook for Lam Research in the near future based on this filing?

The company noted a modest recovery in demand for wafer fabrication equipment in the latter half of fiscal year 2002, supporting an outlook for slightly higher revenues in the first fiscal quarter of 2003 compared to the preceding quarter. However, the overall semiconductor industry remains cyclical, and future performance will depend on market conditions and the company's ability to maintain its competitive position.

What were the major financial impacts from legal settlements and impairments?

In fiscal year 2002, Lam Research recorded a significant charge of $38.8 million related to the settlement of a patent litigation case with Varian Semiconductor Equipment Associates, Inc. Additionally, the company recorded a $9.5 million asset impairment charge related to laboratory and demonstration equipment due to rapid technological changes in the industry.

LRCX 10-K FY2002 Annual Report — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-K filed September 12, 2002. Cited figures are marked; the original filing is the authoritative source.

Lam Research Corporation (LRCX) reported revenues of $943.1 million^a for fiscal year 2002, a significant decrease from $1,519.8 million in fiscal year 2001.

This downturn is attributed to a global decline in demand for integrated circuits, leading to excess capacity in the semiconductor industry and a severe contraction in the semiconductor manufacturing equipment market. The company experienced a net loss of $90.1 million^b in fiscal year 2002, a reversal from the net income of $52.1 million in fiscal year 2001. This performance was impacted by substantial restructuring charges, an asset impairment charge, and a patent litigation settlement.

Despite the challenging market conditions, Lam Research continued to invest in research and development, allocating 19%^c of its revenue to R&D to support customers' transition to smaller device feature sizes, new materials, and 300mm wafers. The company is focused on managing its cost structure and enhancing operational flexibility through outsourcing initiatives. Management expressed optimism for a modest recovery in the first fiscal quarter of 2003, with expectations for slightly higher revenues compared to the prior quarter.

02—Key points

Key Highlights

Revenue declined significantly to $943.1 million in FY2002 from $1,519.8 million in FY2001 due to a downturn in the semiconductor industry.
The company reported a net loss of $90.1 million in FY2002, a sharp contrast to the net income of $52.1 million in FY2001.
Significant restructuring charges ($44.8 million) and an asset impairment charge ($9.5 million) impacted FY2002 results.
Research and Development (R&D) spending remained substantial at $179.2 million (19% of revenue) to support future technological advancements.
The company implemented outsourcing strategies for manufacturing, warehousing, and logistics to enhance operational flexibility.
Backlog increased to $287 million as of June 30, 2002, from $231 million a year prior, indicating potential future demand.
Lam Research repaid its 5% Convertible Subordinated Notes totaling $309.8 million in September 2002, post-fiscal year-end.

03—Questions

Frequently Asked Questions

What led to the significant revenue drop in fiscal year 2002?
The substantial decrease in revenue from $1.52 billion in FY2001 to $943.1 million in FY2002 was primarily driven by a severe contraction in the semiconductor manufacturing equipment market. This was a result of a global decline in demand for integrated circuits, leading to excess capacity among semiconductor manufacturers who subsequently reduced their capital expenditures.
How did Lam Research manage costs and operational efficiency during this downturn?
Lam Research implemented significant cost management programs, including substantial restructuring charges totaling $44.8 million in FY2002. They also entered into agreements to outsource elements of their manufacturing, warehousing, logistics, and IT functions to gain flexibility in scaling operations and responding to the cyclical nature of the business. Reductions in R&D and SG&A expenses were also pursued where possible.
What is the outlook for Lam Research in the near future based on this filing?
The company noted a modest recovery in demand for wafer fabrication equipment in the latter half of fiscal year 2002, supporting an outlook for slightly higher revenues in the first fiscal quarter of 2003 compared to the preceding quarter. However, the overall semiconductor industry remains cyclical, and future performance will depend on market conditions and the company's ability to maintain its competitive position.
What were the major financial impacts from legal settlements and impairments?
In fiscal year 2002, Lam Research recorded a significant charge of $38.8 million related to the settlement of a patent litigation case with Varian Semiconductor Equipment Associates, Inc. Additionally, the company recorded a $9.5 million asset impairment charge related to laboratory and demonstration equipment due to rapid technological changes in the industry.

04—Continue

← View all 10-K filings